286 related articles for article (PubMed ID: 35996953)
1. Lipids and the cancer stemness regulatory system in acute myeloid leukemia.
Lim INX; Nagree MS; Xie SZ
Essays Biochem; 2022 Sep; 66(4):333-344. PubMed ID: 35996953
[TBL] [Abstract][Full Text] [Related]
2. Aberrant Lipid Metabolic Signatures in Acute Myeloid Leukemia.
Singh P; Murali R; Shanmugam SG; Thomas S; Scott J; Warrier S; Arfuso F; Dharmarajan A; Gandhirajan RK
Stem Cells; 2024 Mar; 42(3):200-215. PubMed ID: 38167958
[TBL] [Abstract][Full Text] [Related]
3. CD9, a potential leukemia stem cell marker, regulates drug resistance and leukemia development in acute myeloid leukemia.
Liu Y; Wang G; Zhang J; Chen X; Xu H; Heng G; Chen J; Zhao Y; Li J; Ni Y; Zhang Y; Shan J; Qian C
Stem Cell Res Ther; 2021 Jan; 12(1):86. PubMed ID: 33494824
[TBL] [Abstract][Full Text] [Related]
4. The role of exosomes in the stemness maintenance and progression of acute myeloid leukemia.
Li Q; Wang M; Liu L
Biochem Pharmacol; 2023 Jun; 212():115539. PubMed ID: 37024061
[TBL] [Abstract][Full Text] [Related]
5. Leukemic Stem Cells: From Leukemic Niche Biology to Treatment Opportunities.
Marchand T; Pinho S
Front Immunol; 2021; 12():775128. PubMed ID: 34721441
[TBL] [Abstract][Full Text] [Related]
6. Longitudinal single-cell profiling of chemotherapy response in acute myeloid leukemia.
Naldini MM; Casirati G; Barcella M; Rancoita PMV; Cosentino A; Caserta C; Pavesi F; Zonari E; Desantis G; Gilioli D; Carrabba MG; Vago L; Bernardi M; Di Micco R; Di Serio C; Merelli I; Volpin M; Montini E; Ciceri F; Gentner B
Nat Commun; 2023 Mar; 14(1):1285. PubMed ID: 36890137
[TBL] [Abstract][Full Text] [Related]
7. TIM-3 as a novel therapeutic target for eradicating acute myelogenous leukemia stem cells.
Kikushige Y; Miyamoto T
Int J Hematol; 2013 Dec; 98(6):627-33. PubMed ID: 24046178
[TBL] [Abstract][Full Text] [Related]
8. Determination of P-glycoprotein, MDR-related protein 1, breast cancer resistance protein, and lung-resistance protein expression in leukemic stem cells of acute myeloid leukemia.
de Figueiredo-Pontes LL; Pintão MC; Oliveira LC; Dalmazzo LF; Jácomo RH; Garcia AB; Falcão RP; Rego EM
Cytometry B Clin Cytom; 2008 May; 74(3):163-8. PubMed ID: 18200595
[TBL] [Abstract][Full Text] [Related]
9. Single-Cell Gene Expression Analyses Reveal Distinct Self-Renewing and Proliferating Subsets in the Leukemia Stem Cell Compartment in Acute Myeloid Leukemia.
Sachs K; Sarver AL; Noble-Orcutt KE; LaRue RS; Antony ML; Chang D; Lee Y; Navis CM; Hillesheim AL; Nykaza IR; Ha NA; Hansen CJ; Karadag FK; Bergerson RJ; Verneris MR; Meredith MM; Schomaker ML; Linden MA; Myers CL; Largaespada DA; Sachs Z
Cancer Res; 2020 Feb; 80(3):458-470. PubMed ID: 31784425
[TBL] [Abstract][Full Text] [Related]
10. Identification of TIM-3 as a Leukemic Stem Cell Surface Molecule in Primary Acute Myeloid Leukemia.
Kikushige Y; Miyamoto T
Oncology; 2015; 89 Suppl 1():28-32. PubMed ID: 26551150
[TBL] [Abstract][Full Text] [Related]
11. Zeb1 modulates hematopoietic stem cell fates required for suppressing acute myeloid leukemia.
Almotiri A; Alzahrani H; Menendez-Gonzalez JB; Abdelfattah A; Alotaibi B; Saleh L; Greene A; Georgiou M; Gibbs A; Alsayari A; Taha S; Thomas LA; Shah D; Edkins S; Giles P; Stemmler MP; Brabletz S; Brabletz T; Boyd AS; Siebzehnrubl FA; Rodrigues NP
J Clin Invest; 2021 Jan; 131(1):. PubMed ID: 33108352
[TBL] [Abstract][Full Text] [Related]
12. Oxidative Phosphorylation Fueled by Fatty Acid Oxidation Sensitizes Leukemic Stem Cells to Cold.
Griessinger E; Pereira-Martins D; Nebout M; Bosc C; Saland E; Boet E; Sahal A; Chiche J; Debayle D; Fleuriot L; Pruis M; De Mas V; Vergez F; Récher C; Huls G; Sarry JE; Schuringa JJ; Peyron JF
Cancer Res; 2023 Aug; 83(15):2461-2470. PubMed ID: 37272750
[TBL] [Abstract][Full Text] [Related]
13. Extinguishing the Embers: Targeting AML Metabolism.
Culp-Hill R; D'Alessandro A; Pietras EM
Trends Mol Med; 2021 Apr; 27(4):332-344. PubMed ID: 33121874
[TBL] [Abstract][Full Text] [Related]
14. [Acute myeloid leukemia stem cells from genomic and immunological perspectives].
Goyama S
Rinsho Ketsueki; 2020; 61(9):1130-1137. PubMed ID: 33162508
[TBL] [Abstract][Full Text] [Related]
15. Acute myeloid leukemia: therapeutic targeting of stem cells.
Pabon CM; Abbas HA; Konopleva M
Expert Opin Ther Targets; 2022 Jun; 26(6):547-556. PubMed ID: 35634856
[TBL] [Abstract][Full Text] [Related]
16. Diminished AHR Signaling Drives Human Acute Myeloid Leukemia Stem Cell Maintenance.
Ly M; Rentas S; Vujovic A; Wong N; Moreira S; Xu J; Holzapfel N; Bhatia S; Tran D; Minden MD; Draper JS; Hope KJ
Cancer Res; 2019 Nov; 79(22):5799-5811. PubMed ID: 31519687
[TBL] [Abstract][Full Text] [Related]
17. The cell of origin and the leukemia stem cell in acute myeloid leukemia.
Chopra M; Bohlander SK
Genes Chromosomes Cancer; 2019 Dec; 58(12):850-858. PubMed ID: 31471945
[TBL] [Abstract][Full Text] [Related]
18. Quantitative proteomics reveals specific metabolic features of acute myeloid leukemia stem cells.
Raffel S; Klimmeck D; Falcone M; Demir A; Pouya A; Zeisberger P; Lutz C; Tinelli M; Bischel O; Bullinger L; Thiede C; Flörcken A; Westermann J; Ehninger G; Ho AD; Müller-Tidow C; Gu Z; Herrmann C; Krijgsveld J; Trumpp A; Hansson J
Blood; 2020 Sep; 136(13):1507-1519. PubMed ID: 32556243
[TBL] [Abstract][Full Text] [Related]
19. Nicotinamide phosphoribosyltransferase inhibitors selectively induce apoptosis of AML stem cells by disrupting lipid homeostasis.
Subedi A; Liu Q; Ayyathan DM; Sharon D; Cathelin S; Hosseini M; Xu C; Voisin V; Bader GD; D'Alessandro A; Lechman ER; Dick JE; Minden MD; Wang JCY; Chan SM
Cell Stem Cell; 2021 Oct; 28(10):1851-1867.e8. PubMed ID: 34293334
[TBL] [Abstract][Full Text] [Related]
20. TIM-3 is a promising target to selectively kill acute myeloid leukemia stem cells.
Kikushige Y; Shima T; Takayanagi S; Urata S; Miyamoto T; Iwasaki H; Takenaka K; Teshima T; Tanaka T; Inagaki Y; Akashi K
Cell Stem Cell; 2010 Dec; 7(6):708-17. PubMed ID: 21112565
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]